Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Jardiance's Label Expansion Will Change Diabetes Management

Dec 05 2016

Related Content

BI/Lilly's Jardiance Is First Diabetes Drug With CV Benefit Claim

Dec 02 2016

Boehringer/Lilly's Jardiance Wows With CVOT Data

Sep 18 2015

EASD 2016: Semaglutide Steals The Show With Impressive Cardiovascular Outcomes Data

Sep 16 2016

Jardiance Mortality Claim Narrowly Endorsed By FDA Advisory Committee

Jun 29 2016

Related Companies

Boehringer Ingelheim GmbH

Eli Lilly and Company

Johnson & Johnson

Mitsubishi Tanabe Pharma Corporation

Daiichi Sankyo Co., Ltd.

Additional Topics

Cardiovascular Metabolic Disorders BioPharmaceutical

More from Cardiovascular

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window